HK1196861A1 - 谷草轉氨酶和乳酸脫氫酶的檢測在早期評估抗腫瘤干預措施臨床療效中的應用 - Google Patents

谷草轉氨酶和乳酸脫氫酶的檢測在早期評估抗腫瘤干預措施臨床療效中的應用

Info

Publication number
HK1196861A1
HK1196861A1 HK14110326.8A HK14110326A HK1196861A1 HK 1196861 A1 HK1196861 A1 HK 1196861A1 HK 14110326 A HK14110326 A HK 14110326A HK 1196861 A1 HK1196861 A1 HK 1196861A1
Authority
HK
Hong Kong
Prior art keywords
detection
lactate dehydrogenase
clinical efficacy
aspartate aminotransferase
early evaluation
Prior art date
Application number
HK14110326.8A
Other languages
English (en)
Inventor
楊世方
崔俊生
韋鵬
鄭向君
朱冰
Original Assignee
北京沙東生物技術有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京沙東生物技術有限公司 filed Critical 北京沙東生物技術有限公司
Publication of HK1196861A1 publication Critical patent/HK1196861A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/904Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91188Transferases (2.) transferring nitrogenous groups (2.6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK14110326.8A 2011-08-30 2014-10-16 谷草轉氨酶和乳酸脫氫酶的檢測在早期評估抗腫瘤干預措施臨床療效中的應用 HK1196861A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2011/001464 WO2013029202A1 (zh) 2011-08-30 2011-08-30 谷草转氨酶和乳酸脱氢酶的检测在早期评估抗肿瘤干预措施临床疗效中的应用

Publications (1)

Publication Number Publication Date
HK1196861A1 true HK1196861A1 (zh) 2014-12-24

Family

ID=47755169

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110326.8A HK1196861A1 (zh) 2011-08-30 2014-10-16 谷草轉氨酶和乳酸脫氫酶的檢測在早期評估抗腫瘤干預措施臨床療效中的應用

Country Status (4)

Country Link
US (1) US20140206025A1 (zh)
CN (1) CN103958694B (zh)
HK (1) HK1196861A1 (zh)
WO (1) WO2013029202A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106085980A (zh) * 2016-06-13 2016-11-09 西南医科大学 乳酸脱氢酶同工酶电泳分离方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101074261A (zh) * 2006-04-30 2007-11-21 北京同为时代生物技术有限公司 Trail受体1和/或trail受体2特异性抗体及其应用
US8999661B2 (en) * 2008-07-30 2015-04-07 Dana-Farber Cancer Institute, Inc. Compositions for detecting cell death and methods of use thereof

Also Published As

Publication number Publication date
WO2013029202A1 (zh) 2013-03-07
US20140206025A1 (en) 2014-07-24
CN103958694A (zh) 2014-07-30
CN103958694B (zh) 2016-09-07

Similar Documents

Publication Publication Date Title
EP2793993A4 (en) RECOVERY AND PROCESSING OF HUMAN IN VIVO EMBRYOS
IL228066A0 (en) Methods for diagnosing aneuploidy in human embryos
ZA201400141B (en) Keto-isovalerate decarboxylase enzymes and methods of use thereof
HK1217088A1 (zh) 微泡在醫學疾病和病况的診斷、預後和治療中的用途
EP2761533A4 (en) RECOGNITION OF A HUMAN HEAD ON DEPTH PICTURES
PL2771342T3 (pl) Nowe pochodne puryny i ich zastosowanie w leczeniu chorób
SI2704703T1 (sl) Transdermalni sestavki ibuprofena in postopki za njihovo uporabo
EP2691120A4 (en) THERANOSTIC IMAGING AGENTS AND METHODS OF USE
PT2751279T (pt) Métodos e composições para detetar o nível de atividade de exocitose lisossomal e métodos de utilização
EP2875158A4 (en) USE OF MICROVESICLES IN THE DIAGNOSIS, FORECAST AND TREATMENT OF DISEASES AND MEDICAL SUDDEN
ZA201301234B (en) Methods of reducing blood lactate concentration
HK1251462A1 (zh) 微泡複合物及使用方法
EP2548859A4 (en) PREPARATION OF METHYL-D3-AMINE AND SALTS THEREOF
IL229381B (en) Brilacitidine and its results for use in the treatment of mucositis
IL232115A0 (en) Pharmaceutical preparations that include dgla and/or 15-hetre and methods of using them
HK1198031A1 (zh) 有用於治療濫用藥物及酒精的 衍生物
HK1196535A1 (zh) 鹽及醫藥用途
EP2670438A4 (en) SELECTION AND TREATMENT OF PATIENTS
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
PT2670769T (pt) R2r1/2 em diagnóstico e terapêutica
EP2712368A4 (en) GLUCOSE AND INSULIN SENSORS AND METHODS OF USE
HK1196861A1 (zh) 谷草轉氨酶和乳酸脫氫酶的檢測在早期評估抗腫瘤干預措施臨床療效中的應用
EP2769727A4 (en) USE OF THE DESOXYNUCLEOSIDE / NUCLEOSIDE COMBINATION IN THE MANUFACTURE OF TUMORIC MEDICINAL PRODUCTS
HK1210024A1 (zh) 用於非侵入性檢測和治療在體內缺氧細胞組合物和方法
EP3673923C0 (en) IN VIVO IMAGING OF ENZYMATIC ACTIVITY